Fmr LLC Myriad Genetics Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fmr LLC holds 56,503 shares of MYGN stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,503

Previous 15,800 257.61%

Holding current value

$1.6 Million

Previous $336,000 311.31%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $731,839 - $1.04 Million	40,703 Added 257.61%	56,503 $1.38 Million
Q1 2024 May 13, 2024	BUY	$17.59 - $23.59 $9,797 - $13,139	557 Added 3.65%	15,800 $336,000
Q4 2023 Feb 13, 2024	SELL	$13.91 - $21.32 $2,656 - $4,072	-191 Reduced 1.24%	15,243 $291,000
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $1,039 - $1,509	65 Added 0.42%	15,434 $247,000
Q2 2023 Aug 11, 2023	SELL	$17.56 - $23.76 $5,636 - $7,626	-321 Reduced 2.05%	15,369 $356,000
Q1 2023 May 11, 2023	BUY	$15.26 - $23.75 $141,200 - $219,758	9,253 Added 143.75%	15,690 $364,000
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $151,948 - $219,807	-10,472 Reduced 61.93%	6,437 $93,000
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $4,807 - $7,360	264 Added 1.59%	16,909 $322,000
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $2,023 - $3,183	-123 Reduced 0.73%	16,645 $303,000
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $368,296 - $455,050	16,246 Added 3112.26%	16,768 $423,000
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $13,666 - $16,716	456 Added 690.91%	522 $16,000
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $1,675 - $2,152	66 New	66 $2,000

Others Institutions Holding MYGN

# of Institutions

232

Shares Held

92.6M

Call Options Held

117K

Put Options Held

113K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.28B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account